Boston Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312M Buy
4,037,963
+123,872
+3% +$9.03M 0.28% 122
2026
Q1
$256M Sell
3,914,091
-171,396
-4% -$12.7M 0.27% 134
2025
Q4
$324M Sell
4,085,487
-544,813
-12% -$41.7M 0.34% 102
2025
Q3
$338M Buy
4,630,300
+959,543
+26% +$70.3M 0.35% 96
2025
Q2
$278M Buy
3,670,757
+308,784
+9% +$21.9M 0.31% 112
2025
Q1
$256M Buy
3,361,973
+1,691,565
+101% +$126M 0.31% 112
2024
Q4
$110M Buy
+1,670,408
New +$117M 0.13% 193

Other funds holding SOLV

Boston Partners's SOLV Position: Q2 2026 in Review

Boston Partners increased its Solventum (SOLV) stake by 3.2% in Q2 2026, buying an estimated $9.03M and bringing the position to 4,037,963 shares worth $312M. The position accounts for 0.28% of the portfolio, ranked #122.

Boston Partners first reported a position in SOLV in Q4 2024 and has held it in 7 quarters since. The position peaked at $338M in Q3 2025. 878 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Boston Partners held 4,037,963 shares of Solventum worth $312M as of Q2 2026.
  • Boston Partners bought 123,872 Solventum shares in Q2 2026, an estimated $9.03M.
  • Solventum made up 0.28% of Boston Partners's portfolio in Q2 2026, its #122 holding.
  • Boston Partners first reported a position in Solventum in Q4 2024 and has held it in 7 quarters since.
  • Boston Partners's Solventum position peaked at $338M in Q3 2025.
  • 878 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.